相关实验视频
Updated: Feb 21, 2026

08:35
Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
8.4K
BCL-2 的作用是什么? 从新的分子见解到临床影响
Carlo M Croce1, Stephen W G Tait2,3, Ana J Garcia-Sáez4,5
1Department of Cancer Biology and Genetics and Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA. Carlo.Croce@osumc.edu.
Cell death and differentiation
|February 19, 2026
概括
几十年来对BCL-2家族蛋白质的研究导致了BCL-2抑制剂的开发,通过向细胞亡来彻底改变癌症治疗. 了解抵抗机制和探索新的治疗途径是癌症治疗未来进展的关键.
科学领域:
- 癌症生物学 癌症生物学
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 该BCL-2蛋白家族调节细胞亡,这是细胞死亡的关键过程.
- 调控不良的BCL-2有助于癌症的发病,特别是在淋巴细胞恶性瘤.
- 线粒体外膜透 (MOMP) 是由BCL-2调节的亡的一个关键事件.
研究的目的:
- 审查从BCL-2发现到临床抑制剂开发的旅程.
- 讨论BCL-2在细胞亡调节中的机制及其在癌症中的作用.
- 探索BCL-2向治疗中的挑战,抵抗机制和未来方向.
主要方法:
- 关于BCL-2研究的文献综述,涵盖基础科学到临床应用.
- 分析BCL-2家族相互作用及其在亡中的作用.
- 对血液恶性瘤中BCL-2抑制剂如venetoclax的临床数据的检查.
主要成果:
- 维尼托克拉克斯等BCL-2抑制剂在治疗慢性淋巴细胞白血病 (CLL) 和急性髓性白血病 (AML) 中取得了显著的成功.
- 对BCL-2抑制剂的耐药性可能来自BCL-2突变或其他抗亡蛋白如MCL-1的上调调节.
- 亚致命性MOMP可以触发炎症反应,提供替代治疗点.
结论:
- 向BCL-2已经改变了癌症疗法,特别是在血液癌症.
- 克服耐药性和扩大BCL-2抑制剂对固体瘤的疗效仍然是一个重大挑战.
- 未来的研究应该专注于新型抑制剂,组合疗法,并了解BCL-2的非亡作用.
相关概念视频
The Intrinsic Apoptotic Pathway
8.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.8K
PI3K/mTOR/AKT Signaling Pathway
5.8K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.8K
Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
NF-κB-dependent Signaling Pathway
10.1K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
10.1K
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K

